CD4 and type 1 diabetes mellitus: In participants with T1D ≤ 3 months, AB‐negative and AB‐positive FDR, the increased islet‐specific CD4+ T‐cell autoimmunity presumably indicates ongoing priming of immune cells and epitope spreading to multiple β‐cell antigens prior to, or soon after the clinical manifestation of disease.